Director
Director at Axsome Therapeutics, Inc., filing insider transactions between 2025-06-04 and 2026-06-11. Also reports transactions at 1 other company.
| SEC ↗ |
| 2026-05-26 | LQDA | Sale | 25.0K | $60.38 | $1.5M | SEC ↗ |
| 2026-05-22 | LQDA | Sale | 25.0K | $61.52 | $1.5M | SEC ↗ |
| 2026-05-21 | LQDA | Sale | 25.0K | $61.13 | $1.5M | SEC ↗ |
| 2026-05-20 | LQDA | Sale | 25.0K | $61.30 | $1.5M | SEC ↗ |
| 2026-05-19 | LQDA | Sale | 25.0K | $58.65 | $1.5M | SEC ↗ |
| 2026-05-18 | LQDA | Sale | 25.0K | $56.77 | $1.4M | SEC ↗ |
| 2026-05-15 | LQDA | Sale | 25.0K | $57.04 | $1.4M | SEC ↗ |
| 2026-05-14 | LQDA | Sale | 25.0K | $58.62 | $1.5M | SEC ↗ |
| 2026-05-13 | LQDA | Sale | 25.0K | $56.29 | $1.4M | SEC ↗ |
| 2026-05-12 | LQDA | Sale | 25.0K | $54.04 | $1.4M | SEC ↗ |
| 2026-05-11 | LQDA | Sale | 25.0K | $41.50 | $1.0M | SEC ↗ |
| 2026-05-08 | LQDA | Sale | 25.0K | $42.14 | $1.1M | SEC ↗ |
| 2026-05-07 | LQDA | Sale | 25.0K | $42.09 | $1.1M | SEC ↗ |
| 2026-05-06 | LQDA | Sale | 25.0K | $40.78 | $1.0M | SEC ↗ |
| 2026-05-05 | LQDA | Sale | 25.0K | $40.10 | $1.0M | SEC ↗ |
| 2026-04-17 | LQDA | Sale | 18.8K | $40.60 | $765K | SEC ↗ |
| 2026-04-16 | LQDA | Sale | 25.0K | $40.31 | $1.0M | SEC ↗ |
| 2026-04-15 | LQDA | Sale | 25.0K | $40.14 | $1.0M | SEC ↗ |
| 2026-04-14 | LQDA | Sale | 3,300 | $40.00 | $132K | SEC ↗ |
| 2026-04-13 | LQDA | Sale | 32.7K | $38.37 | $1.3M | SEC ↗ |
| 2026-04-10 | LQDA | Sale | 21.4K | $40.12 | $860K | SEC ↗ |
| 2026-04-09 | LQDA | Sale | 25.0K | $40.12 | $1.0M | SEC ↗ |
| 2026-01-12 | LQDA | Sale | 66.6K | $37.43 | $2.5M | SEC ↗ |
| 2025-10-13 | LQDA | Sale | 20.3K | $23.41 | $474K | SEC ↗ |
| 2025-07-14 | LQDA | Sale | 20.3K | $14.28 | $289K | SEC ↗ |
| 2025-07-14 | LQDA | Sale | 20.3K | $14.28 | $289K | SEC ↗ |
| 2025-06-04 | LQDA | Sale | 30.6K | $16.97 | $519K | SEC ↗ |